Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.

Alex Cruz; Dung-Tsa Chen; William J. Fulp; Michael Chuong; Sarah Hoffe; Ravi Shridhar; Nikhil G Rao; Pamela Joy Hodul; Mokenge Peter Malafa; Nicholas Figura; Edward Eikman; Gregory M. Springett

doi:10.1200/jco.2013.31.4_suppl.310

Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.

Alex Cruz, Dung-Tsa Chen, William J. Fulp, Michael Chuong, Sarah Hoffe, Ravi Shridhar, Nikhil G Rao, Pamela Joy Hodul, Mokenge Peter Malafa, Nicholas Figura, Edward Eikman, Gregory M. Springett

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	31
DOIs	https://doi.org/10.1200/jco.2013.31.4_suppl.310
State	Published - Jan 2 2013

Disciplines

Radiology
Medicine and Health Sciences

Access to Document

10.1200/jco.2013.31.4_suppl.310License: Unspecified

Cite this

Cruz, A., Chen, D.-T., Fulp, W. J., Chuong, M., Hoffe, S., Shridhar, R., Rao, N. G., Hodul, P. J., Malafa, M. P., Figura, N., Eikman, E., & Springett, G. M. (2013). Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy. Journal of Clinical Oncology, 31. https://doi.org/10.1200/jco.2013.31.4_suppl.310

Cruz, A, Chen, D-T, Fulp, WJ, Chuong, M, Hoffe, S, Shridhar, R, Rao, NG, Hodul, PJ, Malafa, MP, Figura, N, Eikman, E & Springett, GM 2013, 'Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.', Journal of Clinical Oncology, vol. 31. https://doi.org/10.1200/jco.2013.31.4_suppl.310

@article{756c31bbb2a24eb0b09d7aa34986e921,

title = "Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.",

author = "Alex Cruz and Dung-Tsa Chen and Fulp, {William J.} and Michael Chuong and Sarah Hoffe and Ravi Shridhar and Rao, {Nikhil G} and Hodul, {Pamela Joy} and Malafa, {Mokenge Peter} and Nicholas Figura and Edward Eikman and Springett, {Gregory M.}",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2013",

month = jan,

day = "2",

doi = "10.1200/jco.2013.31.4_suppl.310",

language = "American English",

volume = "31",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.

AU - Cruz, Alex

AU - Chen, Dung-Tsa

AU - Fulp, William J.

AU - Chuong, Michael

AU - Hoffe, Sarah

AU - Shridhar, Ravi

AU - Rao, Nikhil G

AU - Hodul, Pamela Joy

AU - Malafa, Mokenge Peter

AU - Figura, Nicholas

AU - Eikman, Edward

AU - Springett, Gregory M.

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2013/1/2

Y1 - 2013/1/2

UR - http://ascopubs.org/doi/abs/10.1200/jco.2013.31.4_suppl.310

U2 - 10.1200/jco.2013.31.4_suppl.310

DO - 10.1200/jco.2013.31.4_suppl.310

M3 - Article

VL - 31

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Pretreatment metabolic tumor volume (MTV) as a predictor of survival in borderline resectable pancreatic cancers treated with neoadjuvant therapy.

Disciplines

Access to Document

Other files and links

Cite this